NME8 Gene Primary ciliary dyskinesia type 6 Genetic Test
At DNA Labs UAE, we offer the NME8 Gene Primary ciliary dyskinesia type 6 Genetic Test. This test is designed to identify mutations or variations in the NME8 gene, which is associated with primary ciliary dyskinesia type 6, a genetic disorder affecting the function of cilia.
Test Details
The NME8 gene is associated with primary ciliary dyskinesia type 6, a genetic disorder that affects the function of cilia. Cilia are tiny hair-like structures found on the surface of cells that help with the movement of mucus, fluids, and particles in the body.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that analyzes multiple genes simultaneously to identify mutations or variations in the DNA sequence. In the case of primary ciliary dyskinesia type 6, NGS genetic testing can be used to identify mutations in the NME8 gene that may be causing the disorder.
Test Components and Price
- Test Name: NME8 Gene Primary ciliary dyskinesia type 6 Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Before undergoing the NME8 Gene Primary ciliary dyskinesia type 6 Genetic Test, it is important to provide the clinical history of the patient. This test is specifically recommended for individuals who are going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session is conducted to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER19.
Test Process
The NME8 Gene Primary ciliary dyskinesia type 6 Genetic Test involves obtaining a DNA sample, usually through a blood sample or cheek swab. The DNA sample is then analyzed using NGS technology to identify mutations or variations in the NME8 gene. This test helps confirm a diagnosis of primary ciliary dyskinesia type 6 and provides information about the specific genetic mutation involved.
Benefits of Genetic Testing
Genetic testing can be helpful for individuals with symptoms suggestive of primary ciliary dyskinesia type 6 as it provides a definitive diagnosis and helps guide treatment and management options. It is also useful for family members of individuals with the disorder as it determines if they are at risk of developing primary ciliary dyskinesia type 6 or passing it on to their children.
Consultation
It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of NGS genetic testing for primary ciliary dyskinesia type 6. They can provide more specific information and guidance based on individual circumstances.
| Test Name | NME8 Gene Primary ciliary dyskinesia type 6 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER19 |
| Test Details |
The NME8 gene is associated with primary ciliary dyskinesia type 6, a genetic disorder that affects the function of cilia. Cilia are tiny hair-like structures found on the surface of cells that help with the movement of mucus, fluids, and particles in the body. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that analyzes multiple genes simultaneously to identify mutations or variations in the DNA sequence. In the case of primary ciliary dyskinesia type 6, NGS genetic testing can be used to identify mutations in the NME8 gene that may be causing the disorder. The NGS genetic test for primary ciliary dyskinesia type 6 involves obtaining a DNA sample, usually through a blood sample or cheek swab, and analyzing the DNA for mutations or variations in the NME8 gene. This test can help confirm a diagnosis of primary ciliary dyskinesia type 6 and provide information about the specific genetic mutation involved. Genetic testing can be helpful for individuals with symptoms suggestive of primary ciliary dyskinesia type 6, as it can provide a definitive diagnosis and help guide treatment and management options. It can also be useful for family members of individuals with the disorder, as it can determine if they are at risk of developing primary ciliary dyskinesia type 6 or passing it on to their children. It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of NGS genetic testing for primary ciliary dyskinesia type 6. They can provide more specific information and guidance based on individual circumstances. |
